We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
1
1.Greenblatt, DJ, Koch-Weser, J, Clinical pharmacokinetics (first of two parts). N Engl J Med1975;293:702–705.CrossRefGoogle ScholarPubMed
2
2.Gibaldi, M, Boyes, RN, Feldman, S, Influence of first-pass effect on availability of drugs on oral administration, J Pharm Sci1971;60:1338–1340.CrossRefGoogle ScholarPubMed
3
3.Finn, AL, Taylor, WJ, Kane, WJ, General principles. Practical applications of serum concentration monitoring, in Individualizing Drug Therapy: Practical Application of Drug Monitoring. New York, Gross Townsend Frank Inc, 1981, pp 2–30.Google Scholar
5.Thompson, MIB, Russo, ME, Saxon, BJ, et al: Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease. Antimicrob Agents Chemother1982;21:268–273.CrossRefGoogle ScholarPubMed
6
6.Ervin, FR, Bullock, WE, Nuttall, CE, Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother1976;9:1004–1011.CrossRefGoogle ScholarPubMed
7
7.Blair, DC, Duggan, DO, Schroeder, ET, Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure. Antimicrob Agents Chemother1982;22:376–379.CrossRefGoogle ScholarPubMed
8
8.Glazko, AJ, Dill, WA, Kinkel, AW, et al: Absorption and excretion of parenteral doses of chloramphenicol sodium succinate in comparison with peroral doses of chloramphenicol. Clin Pharmacol Ther1977;21:104.Google Scholar
9
9.Brogden, RN, Heel, RC, Speight, TM, et al: Metronidazole in anaerobic infections: A review of its activity, pharmacokinetics and therapeutic use. Drugs1978;16:387–417.CrossRefGoogle ScholarPubMed
10
10.Greenblatt, DJ, Koch-Weser, J, Intramuscular injection of drugs. N Engl J Med1976;295:542–546.Google ScholarPubMed
11
11.Wise, R, Protein binding of B-lactams: The ef fects on activity and pharmacology particularly tissue penetration. Antimicrob Agents Chemother1983;12:105–118.CrossRefGoogle Scholar
12
12.Eliopoulis, GM, Moellering, RC, Azlocillin, mezlocillin and piperacillin: New broad-spectrum penicillins. Ann Intern Med1982;97:755–760.CrossRefGoogle Scholar
13
13.Greenblatt, DJ, Koch-Weser, J, Clinical pharmacokinetics (second of two parts). NEngl J Med1975;293:964–970.CrossRefGoogle ScholarPubMed
14
14.Lesar, TS, Rotschafer, JC, Strand, LM, et al: Gentamicin dosing errors with four commonly used nomograms. JAMA1982;248:1190–1193.CrossRefGoogle ScholarPubMed
15
15.Cockcroft, DW, Gault, MH, Prediction of creatinine clearance from serum creatinine. Nephron1976;16:31.CrossRefGoogle ScholarPubMed
16
16.Spyker, DA, Guerrant, RL, Dosage nomograms for aminoglycoside antibiotics. Hospital Formulary1981;16:132–139.Google Scholar